Cargando…
COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884605/ https://www.ncbi.nlm.nih.gov/pubmed/38013776 http://dx.doi.org/10.1016/j.imj.2023.01.004 |
| _version_ | 1784879752648065024 |
|---|---|
| author | Hoption Cann, Stephen A. |
| author_facet | Hoption Cann, Stephen A. |
| author_sort | Hoption Cann, Stephen A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9884605 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98846052023-01-30 COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger? Hoption Cann, Stephen A. Infectious Medicine Commentary The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press. 2023-03 2023-01-30 /pmc/articles/PMC9884605/ /pubmed/38013776 http://dx.doi.org/10.1016/j.imj.2023.01.004 Text en © 2023 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Hoption Cann, Stephen A. COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger? |
| title | COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger? |
| title_full | COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger? |
| title_fullStr | COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger? |
| title_full_unstemmed | COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger? |
| title_short | COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger? |
| title_sort | covid-19 vaccine-related myocarditis: could antipyretic drugs be a trigger? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884605/ https://www.ncbi.nlm.nih.gov/pubmed/38013776 http://dx.doi.org/10.1016/j.imj.2023.01.004 |
| work_keys_str_mv | AT hoptioncannstephena covid19vaccinerelatedmyocarditiscouldantipyreticdrugsbeatrigger |